Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pill-sized imaging device correctly spots Barrett's esophagus
FierceMedicalDevice
Monday, January 14, 2013 - 7:23pm
tags:
imaging, innovation, technology, devices, ninepoint medical
Indian stent makers target international markets
FierceMedicalDevice
Monday, January 14, 2013 - 7:22pm
tags:
India, stent, international
FDA Warns St. Jude of "Non-Conformities" at California Plant
The Motley Fool
Monday, January 14, 2013 - 7:18pm
tags:
FDA, St. Jude Medical, safety, devices
Celsion's Got No Reason to Be Blue
The Motley Fool
Monday, January 14, 2013 - 7:10pm
tags:
Celsion, earnings
Covidien Opens Patient Enrollment for SWIFT PRIME Acute Ischemic Stroke Study
Yahoo/BusinessWire
Monday, January 14, 2013 - 7:09pm
tags:
Covidien, patient, clinical trials, stroke, research, devices
Baxter International Fourth Quarter 2012 Financial Results Conference Call
Yahoo/BusinessWire
Monday, January 14, 2013 - 7:08pm
tags:
Baxter International, earnings
JPMorgan Healthcare Conference Highlights: PDL BioPharma
Motley Fool
Monday, January 14, 2013 - 1:16pm
tags:
PDL Biopharma, JPMHC 2013
Halozyme Moving Higher On Fundamentals, Analyst Upgrade
Seeking Alpha
Monday, January 14, 2013 - 1:15pm
tags:
Halozyme
Patients laud Lundbeck, Gilead, but give pharma's rep low marks
Fierce Pharma
Monday, January 14, 2013 - 1:15pm
tags:
patients, Lundbeck, Gilead
Pfizer On The Move: A Rise In Dividend, Precious Approvals Gained
Seeking Alpha
Monday, January 14, 2013 - 12:31pm
tags:
dividends, drug approvals, Pfizer, Eliquis, Portola Pharmaceuticals
JPMorgan Healthcare Conference Highlights: Exelixis
Motley Fool
Monday, January 14, 2013 - 12:30pm
tags:
Exelixis, JPMHC 2013, Cometriq, medullary thyroid cancer
Will Forest Labs Earn or Burn Tomorrow?
Motley Fool
Monday, January 14, 2013 - 12:29pm
tags:
earnings, Forest Labs
Pfizer Said to Weigh Purchase of Strides Unit Agila Specialties
Bloomberg
Monday, January 14, 2013 - 12:28pm
tags:
Pfizer, M&A, Agila, Strides Arcolab, India, injectables
Is Tranzyme A Takeover Target For Bristol-Myers Squibb?
Seeking Alpha
Monday, January 14, 2013 - 12:28pm
tags:
M&A, Bristol-Myers Squibb, Tranzyme
Otsuka Can Block Generic Abilify as Court Rejects Appeal
Bloomberg
Monday, January 14, 2013 - 12:27pm
tags:
generics, Abilify, Otsuka, schizophrenia
Amgen Q4 Earnings Preview: A Banner 2013 For The King Of Biotech
Seeking Alpha
Monday, January 14, 2013 - 12:26pm
tags:
earnings, Amgen
GSK files for U.S. approval of new diabetes drug
Reuters
Monday, January 14, 2013 - 12:04pm
tags:
GSK, diabetes, albiglutide
JPMorgan Healthcare Conference Rewind: Rigel Pharmaceuticals
Motley Fool
Monday, January 14, 2013 - 12:01pm
tags:
JPMHC 2013, Rigel Pharmaceuticals
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Monday, January 14, 2013 - 12:00pm
tags:
JNJ, diabetes, FDA, canagliflozin
[video]Dendreon: 3 Areas You Must Watch
Motley Fool
Monday, January 14, 2013 - 11:59am
tags:
Dendreon, Provenge

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.